Article
Targeting the actin nucleation promoting factor WASp provides a therapeutic approach for hematopoietic malignancies
22 Sept 2021
Abstract excerpt
Cancer cells depend on actin cytoskeleton rearrangement to carry out hallmark malignant functions including activation, proliferation, migration and invasiveness. Wiskott-Aldrich Syndrome protein (WASp) is an actin nucleation-promoting factor and is a key regulator of actin polymerization in hematopoietic cells. The involvement of WASp in malignancies is incompletely understood. Since WASp is exclusively...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
